Oncolytics Biotech

Oncolytics Biotech

Developing pelareorep, an IV delivered I-O virus, promoting an inflamed tumor: waking the immune system.

HQ location
Calgary, Canada
Website
oncolyticsbiotech.com
Launch date
Employees
11-50 people
Market cap
$105m
Enterprise value
$94m
Share price
CAD1.42 ONC.TO
Jobs
View job openings
https://twitter.com/oncolyticshttps://www.facebook.com/oncolytics.biotech.inchttps://www.linkedin.com/company/oncolytics-biotech-inc./
Authorizing premium user...